Mencari ubat atas namanya

Zonacort Tablets dan Osteoporosis

Hasil ujian interaksi ubat Zonacort Tablets dan penyakit Osteoporosis untuk kontraindikasi dan kesan sampingan dengan penggunaan bersama.

Hasil pemeriksaan:
Zonacort Tablets <> Osteoporosis
Relevan: 23.07.2019 Pengulas: MD P.M. Shkutko, in

Kontraindikasi atau kesan sampingan yang boleh membahayakan atau meningkatkan kesan negatif apabila menggunakan ubat dengan penyakit ditemui saat pemeriksaan interaksi mengikut sumber yang bereputasi - Drugs.com, RXList.com, Webmd.com, MedScape.com.

Pengguna:

Steroid mengurangkan osteoblastic fungsi dan menghalang penyerapan usus kalsium, yang boleh menyebabkan tulang penyerapan dan tulang kehilangan semasa berpanjangan terapi. Di samping itu, tulang matrix boleh dipengaruhi oleh protein-katabolik kesan steroid, terutama ketika diberikan dalam dos yang tinggi atau untuk tempoh yang lama, terkemuka untuk k kebekuan dan patah. Jangka panjang atau tinggi-dos terapi kortikosteroid perlu diberikan berhati-hati, dan hanya jika perlu pada pasien dengan atau berisiko untuk diuji. Buruk rangka kesan mungkin diminimumkan oleh ganti-hari atau terputus-putus pentadbiran. Apa-apa pasien menerima berpanjangan terapi dengan bersamaan 7.5 mg prednisone/hari atau lebih berisiko untuk glukokortikoid-induced diuji dan harus berjaya menurut Amerika College of Rheumatology (ACR) garis panduan.

Sumber
  • Goldstein MF, Fallon JJ, Harning R "Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease." Chest 116 (1999): 1733-49
  • Anderton JM, Helm R "Multiple joint osteonecrosis following short-term steroid therapy. Case report." J Bone Joint Surg Am 64 (1982): 139-41
  • Seale JP, Compton MR "Side-effects of corticosteroid agents." Med J Aust 144 (1986): 139-42
  • "Product Information. Deltasone (prednisone)." Pharmacia and Upjohn, Kalamazoo, MI.
  • "Product Information. Medrol (methylprednisolone)." Pharmacia and Upjohn, Kalamazoo, MI.
  • Black KA, Khangure MS, Owen ET "Dexamethasone and osteonecrosis." Aust N Z J Med 11 (1981): 521-5
  • Rizzato G, Montemurro L "Reversibility of exogenous corticosteroid-induced bone loss." Eur Respir J 6 (1993): 116-9
  • "Product Information. Celestone (betamethasone)." Schering Corporation, Kenilworth, NJ.
  • Fordyce MJ, Solomon L "Early detection of avascular necrosis of the femoral head by MRI." J Bone Joint Surg Br 75 (1993): 365-7
  • Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998):
  • Archer AG, Nelson MC, Abbondanzo SL, Bogumill GP "Case report 554: Osteonecrosis at multiple sites as noted." Skeletal Radiol 18 (1989): 380-4
  • Mitchison HC, Bassendine MF, Malcolm AJ, et al "A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss." Hepatology 10 (1989): 420-9
  • Taylor LJ "Multifocal avascular necrosis after short-term high-dose steroid therapy. A report of three cases." J Bone Joint Surg Br 66 (1984): 431-3
  • McCluskey J, Gutteridge DH "Avascular necrosis of bone after high doses of dexamethasone during neurosurgery." Br Med J (Clin Res Ed) 284 (1982): 333-4
  • Fast A, Alon M, Weiss S, Zer-Aviv FR "Avascular necrosis of bone following short-term dexamethasone therapy for brain edema. Case report." J Neurosurg 61 (1984): 983-5
  • Saisu T, Sakamoto K, Yamada K, Kashiwabara H, Yokoyama T, Iida S, Harada Y, Ikenoue S, Sakamoto M, Moriya H "High incidence of osteonecrosis of femoral head in patients receiving more than 2 g of intravenous methylprednisolone after renal transplantation." Transplant Proc 28 (1996): 1559-60
  • "Product Information. Florinef Acetate (fludrocortisone)." Bristol-Myers Squibb, Princeton, NJ.
  • Bijlsma JW, Duursma SA, Bosch R, Raymakers JA, Huber-Bruning O "Acute changes in calcium and bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis." Br J Rheumatol 27 (1988): 215-9
  • Thomas TP "The complications of systemic corticosteroid therapy in the elderly." Gerontology 30 (1984): 60-5
  • "Product Information. Kenalog (triamcinolone)." Bristol-Myers Squibb, Princeton, NJ.
  • Elliott ME, Farrah RM, Binkley NC, Cames ML, Gudmundsson A "Management of glucocorticoid-induced osteoporosis in male veterans." Ann Pharmacother 34 (2000): 1380-4
  • Marystone JF, Barrettconnor EL, Morton DJ "Inhaled and oral corticosteroids: their effects on bone mineral density in older adults." Am J Public Health 85 (1995): 1693-5
  • Sambrook PN, Hassall JE, York JR "Osteonecrosis after high dosage, short term corticosteroid therapy." J Rheumatol 11 (1984): 514-6
  • Cruess RL "Experience with steroid-induced avascular necrosis of the shoulder and etiologic considerations regarding osteonecrosis of the hip." Clin Orthop Jan-Feb(13 (1978): 86-93
  • "Product Information. Decadron (dexamethasone)." Merck & Co, Inc, West Point, PA.
  • Hahn TJ, Halstead LR, Baran DT "Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin d metabolite concentrations in man." J Clin Endocrinol Metab 52 (1981): 111-5
  • Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM "Bone density in asthmatic patients taking high dose inhaled beclomethasone diproprionate and intermittent systemic corticosteroids." Thorax 47 (1992): 414-7
  • Ledford D, Apter A, Brenner AM, Rubin K, Prestwood K, Frieri M, Lukert B "Osteoporosis in the corticosteroid-treated patient with asthma." J Allergy Clin Immunol 102 (1998): 353-62
  • Mizuta H, Kubota K, Shiraishi M, Kai K, Nakamura E, Takagi K "Steroid-related bilateral osteonecrosis of the patella." Arthroscopy 9 (1993): 114-6
  • Weissman DE, Dufer D, Vogel V, Abeloff MD "Corticosteroid toxicity in neuro-oncology patients." J Neurooncol 5 (1987): 125-8
  • "Product Information. Hydrocortone (hydrocortisone)." Merck & Co, Inc, West Point, PA.
  • Need AG, Philcox JC, Hartley TF, Nordin BE "Calcium metabolism and osteoporosis in cortiscosteroid-treated postmenopausal women." Aust N Z J Med 16 (1986): 341-6
  • "Product Information. Hydeltrasol (prednisolone)." Merck & Co, Inc, West Point, PA.
  • Williams IA, Mitchell AD, Rothman W, Tallett P, Williams K, Pitt P "Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone." Ann Rheum Dis 47 (1988): 930-3
  • Fentiman IS, Saad Z, Caleffi M, et al "Tamoxifen protects against steroid-induced bone loss." Eur J Cancer 28 (1992): 684-5
  • "Product Information. Cortone Acetate (cortisone)." Merck & Co, Inc, West Point, PA.
Zonacort Tablets

Nama jenerik: dexamethasone

Jenama: Baycadron, Dexamethasone Intensol, DexPak 10 Day Taperpak, DexPak 13 DayTaperpak, DexPak 6 DayTaperpak, De-Sone LA, Dexacen-4, Dexasone, Dexasone LA, Solurex, Solurex LA, Decadron, DexPak, TaperDex, Zema-Pak, ZoDex, Zonacort

Sinonim: tidak

Interaksi dengan makanan dan gaya hidup
Interaksi ubat-ubatan